Clinical trial
A Study of Tucaresol in HIV-Infected Patients Who Are Taking Other Anti-HIV…
NCT00006209 · Aaron Diamond AIDS Research Center, Other · Unknown status
Key facts
| NCT number | NCT00006209 |
|---|---|
| Title | A Study of Tucaresol in HIV-Infected Patients Who Are Taking Other Anti-HIV Drugs |
| Official title | A Phase I Open-Label Dose Escalation Trial of Tucaresol in HIV-1 Infected Subjects Taking Potent Antiretroviral Therapy |
| Lead sponsor | Aaron Diamond AIDS Research Center, Other |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Tucaresol |
| Enrollment | 24 |
| Start date | Jun 1, 2000 |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: